Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile
- PMID: 33876817
- PMCID: PMC8212768
- DOI: 10.1093/jac/dkab097
Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile
Abstract
Background: Until recently, metronidazole was the first-line treatment for Clostridioides difficile infection and it is still commonly used. Though resistance has been reported due to the plasmid pCD-METRO, this does not explain all cases.
Objectives: To identify factors that contribute to plasmid-independent metronidazole resistance of C. difficile.
Methods: Here, we investigate resistance to metronidazole in a collection of clinical isolates of C. difficile using a combination of antimicrobial susceptibility testing on different solid agar media and WGS of selected isolates.
Results: We find that nearly all isolates demonstrate a haem-dependent increase in the MIC of metronidazole, which in some cases leads to isolates qualifying as resistant (MIC >2 mg/L). Moreover, we find an SNP in the haem-responsive gene hsmA, which defines a metronidazole-resistant lineage of PCR ribotype 010/MLST ST15 isolates that also includes pCD-METRO-containing strains.
Conclusions: Our data demonstrate that haem is crucial for medium-dependent metronidazole resistance in C. difficile.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
Figures




Similar articles
-
Sequence-Based Identification of Metronidazole-Resistant Clostridioides difficile Isolates.Emerg Infect Dis. 2022 Nov;28(11):2308-2311. doi: 10.3201/eid2811.220615. Emerg Infect Dis. 2022. PMID: 36286226 Free PMC article.
-
Detection of Plasmid-Mediated Resistance to Metronidazole in Clostridioides difficile from River Water.Microbiol Spectr. 2022 Aug 31;10(4):e0080622. doi: 10.1128/spectrum.00806-22. Epub 2022 Aug 11. Microbiol Spectr. 2022. PMID: 35950844 Free PMC article.
-
Newly emerging metronidazole-resistant Clostridioides difficile PCR ribotype 955 identified in Poland, 2021 to 2023 but not in Czechia, 2012 to 2023 and Slovakia, 2015 to 2023.Euro Surveill. 2025 May;30(21):2400675. doi: 10.2807/1560-7917.ES.2025.30.21.2400675. Euro Surveill. 2025. PMID: 40444372 Free PMC article.
-
A narrative review of Clostridioides difficile infection in China.Anaerobe. 2022 Apr;74:102540. doi: 10.1016/j.anaerobe.2022.102540. Epub 2022 Feb 24. Anaerobe. 2022. PMID: 35219837 Review.
-
Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view?Int J Infect Dis. 2022 Nov;124:118-123. doi: 10.1016/j.ijid.2022.09.013. Epub 2022 Sep 22. Int J Infect Dis. 2022. PMID: 36155825 Review.
Cited by
-
Clostridioides difficile Infection: Diagnosis and Treatment Challenges.Pathogens. 2024 Jan 27;13(2):118. doi: 10.3390/pathogens13020118. Pathogens. 2024. PMID: 38392856 Free PMC article. Review.
-
Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences.J Antimicrob Chemother. 2024 Jun 3;79(6):1320-1328. doi: 10.1093/jac/dkae101. J Antimicrob Chemother. 2024. PMID: 38598696 Free PMC article.
-
Haemin deprivation renders Bacteroides fragilis hypersusceptible to metronidazole and cancels high-level metronidazole resistance.J Antimicrob Chemother. 2022 Mar 31;77(4):1027-1031. doi: 10.1093/jac/dkab485. J Antimicrob Chemother. 2022. PMID: 35040989 Free PMC article.
-
Antibiotic Resistance and Biofilm Production Capacity in Clostridioides difficile.Front Cell Infect Microbiol. 2021 Aug 4;11:683464. doi: 10.3389/fcimb.2021.683464. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34422678 Free PMC article.
-
Genomic islands and molecular mechanisms relating to drug-resistance in Clostridioides (Clostridium) difficile PCR ribotype 176.Emerg Microbes Infect. 2025 Dec;14(1):2482698. doi: 10.1080/22221751.2025.2482698. Epub 2025 Apr 9. Emerg Microbes Infect. 2025. PMID: 40130321 Free PMC article.
References
-
- Chang JY, Antonopoulos DA, Kalra A. et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008; 197: 435–8. - PubMed
-
- Rupnik M, Wilcox MH, Gerding DN.. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009; 7: 526–36. - PubMed
-
- Ooijevaar RE, van Beurden YH, Terveer EM. et al. Update of treatment algorithms for Clostridium difficile infection. Clin Microbiol Infect 2018; 24: 452–62. - PubMed
-
- McDonald LC, Gerding DN, Johnson S. et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018; 66: 987–94. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources